Filter By

Refinements

Clear All Refinements

Antibody type

Mouse Monoclonal (10)

Rabbit Monoclonal (12)

Localization

Cell Wall (2)

Cytoplasmic (4)

Cytoplasmic, Membranous (1)

Cytoplasmic, Nuclear (5)

Cytoplasmic, Perinuclear (1)

Membranous (1)

Nuclear (8)

Navigate:

StoreFront / New Products

24 New IHC Antibodies

Breast, Carcinoma, Colon, Hodgkin’s Lymphoma, Infectious Disease >
Kidney, Lung, Neuroendocrine, Sarcoma >
Thyroid & Parathyroid, and Testicular Cancer Applications >

4 New Substrate-Chromogens

See Details >

>> Click Here to Download our 2022 New Products Brochure <<

New Antibodies for Breast Cancer Applications Cathepsin K, MMab CITED1, MMab Cyclin D3, MMab MAGEC2, RMab MUC1, RMab TRPS1, RMab	New Antibodies for Colon & G.I Applications Cathepsin K, MMab CEACAM7, MMab LRG1, MMab MLH1, RMab MUC1, RMab
New Antibodies for Sarcoma and Soft Tissue Cancer Applications NUTM1, RMab SS18-SSX, RMab TLE1, RMab Tri-Methyl-Histone H3 (Lys27)/H3K27Me3, RMab	New Antibodies for Neural and Neuroendocrine Cancer Applications APOE4, MMab Ptau Phospho, MMab Tri-Methyl-Histone H3 (Lys27)/H3K27Me3, RMab ZFAND3, MMab
New Antibodies for Lung Cancer Applications Claudin-4, RMab DDR1, MMab Napsin A, RMab	New Antibodies for Prostate Cancer Applications Cathepsin K, MMab Cyclin D3, MMab
New Antibodies for Liver Cancer Applications DDR1, MMab LRG1, MMab	New Antibodies for Carcinomas of Unknown Primary Site Applications Napsin A, RMab
New Antibodies for Kidney and Urothelial Cancer Applications PAX-8, RMab DDR1, MMab	New Antibodies for Lymphoma Cancer Applications Tri-Methyl-Histone H3 (Lys27)/H3K27Me3, RMab NUTM1, RMab
New Antibodies for Melanoma and Skin Cancer Applications MLH1, RMab Tri-Methyl-Histone H3 (Lys27)/H3K27Me3, RMab	New Antibodies for Thyroid and Parathyroid Cancer Applications Cyclin D3, MMab
New Antibodies for Infectious Disease Cancer Applications Candida Albicans, RMab Aspergillus, RMab	New Antibodies for Mesothelioma Applications Claudin-4, RMab
New Antibodies for Leukemia Applications TORC3 / CRTC3, MMab	New Antibodies for Head and Neck Cancer Applications NUTM1, RMab